Main Menu

  • About Journal
  • Aims and Scope
  • Editorial Board
  • Submit Your Article
  • Instructions to Authors
  • Indexing/Abstracting
  • Archive
  • PIIs
  • Publication Ethics
  • Join/Contact us

Most read content

  • About Journal
  • Call For Papers
  • Editorial Board
  • Copyright & Publishing Rights Policy
  • Instructions to Authors

News & Views

  • Hormone therapy may improve psychological functioning in transgender individuals
  • Mood disorder experts question effectiveness of metyrapone drug
  • Cornell Food and Brand Lab researchers develop online Global Healthy Weight Registry
  • Conference Alerts by Conal

Partner Journals

  • Journal of Life Sciences and Biomedicine
  • World's Veterinary Journal
  • Journal of World's Poultry Research
  • submit-your-article+
PDF | Print | E-mail

Previous issue | Next issue | Archive

Volume 9 (2); 25 June, 2019

Graphical_abstractResearch Paper

Toxicity and Efficacy Study of Novel Herbal Formulation of Hadjoint® Tablets.

Cordeiro MC.

Asian J. Med. Pharm. Res., 9(2): 11-16, 2019; pii:S2252043019000002-9

Abstract

Osteoarthritis, one of the most common forms of arthritis is a cause of concern especially in women and the elderly age group. Alternative modes of treatment like herbal medicines are preferred, since conventional methods of treatment do not treat the underlying cause. HADJOINT® tablet, a novel herbal formulation was prepared by combining different plant extracts like Cissus quadrangularis, Moringa oleifera, Emblica officinalis and others. The aim of the study was to determine the toxicity and efficacy of the herbal formulation in adjuvant induced osteoarthritis in Wistar rats. The study found HADJOINT® to be non-toxic till 2000 mg/kg body weight. It also showed lowered levels of erythema, edema and limping indicating reduced arthritis. The absence of clinical signs of mortality or toxicity, changes in hematology and biochemical parameters on treatment implies safety and efficacy potential comparable to Diclofenac.

Keywords: Edema, Erythema, Osteoarthritis, Toxicity

[Full text-PDF]


Previous issue | Next issue | Archive



Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 
Delicious

© 2025

Scienceline is a non-profit organisation inspired by research funders and led by scholars. Our mission is to help researchers accelerate discovery and innovation

by operating a platform for research communication that encourages and recognises the most responsible behaviours in science.


Scienceline Publications, Ltd is a limited liability non-profit non-stock corporation registered in the State of Erzurum, Turkey,

with company number 0757086921600001, and branch number 18677/25379 at the address:


Scienceline Publications, Ltd

Ömer Nasuhi Bilmen Road

Dönmez Apart., G1/6

Yakutiye, Erzurum 25100

Turkey

Scienceline Publications, Ltd. Subject to a Creative Commons Attribution license (CC BY-NC 4.0), except where otherwise noted.

Designed By Scienceline Publishing Group